Neuralink, Elon Musk's brain-computer interface startup, also made progress despite facing challenges, including an FDA denial to begin human trials and an investigation into animal cruelty claims. The company was cleared by the FDA to begin early-stage human trials in May. Gaming handhelds also saw an explosion of compelling devices, offering big performance and the freedom to play any title.
Key takeaways:
- Threads, a standalone Twitter clone by Meta, has emerged as a popular alternative with 100 million monthly users, benefiting from Elon Musk's controversial actions on Twitter.
- Generative AI has seen significant advancements in 2023 with Microsoft's Bing Chat and Google's Bard chatbot, although there are still concerns about AI ethics and potential misuse.
- Apple has made surprising moves towards open standards in 2023, introducing USB-C charging ports and supporting the RCS messaging standard, while also launching the Vision Pro, a high-end VR headset.
- Despite initial setbacks, Elon Musk's Neuralink has been cleared by the FDA to begin early-stage human trials, aiming to enable people with paralysis to control external devices with their thoughts.